# SCN10A

## Overview
SCN10A is a gene that encodes the sodium voltage-gated channel alpha subunit 10, also known as NaV1.8, which is a transmembrane protein primarily expressed in the peripheral nervous system. This protein is a critical component of voltage-gated sodium channels, which are essential for the initiation and propagation of action potentials in excitable cells. NaV1.8 is particularly significant in the context of pain signaling and cardiac conduction, where it contributes to the late sodium current (INaL) in cardiac cells, influencing arrhythmogenesis and cardiac rhythm (Hartmann2023Molecular; SavioGalimberti2012VoltageGated). The gene's expression and function are modulated by various interactions and post-translational modifications, which can impact its role in physiological and pathological conditions, including cardiac arrhythmias and reproductive functions (CejudoRoman2013The; Wu2021Calmodulin).

## Structure
The SCN10A gene encodes the Na V 1.8 voltage-gated sodium channel, primarily expressed in the peripheral nervous system. The protein's primary structure consists of a sequence of amino acids forming the channel, organized into four homologous domains (DI-DIV), each containing six transmembrane segments (S1-S6) (SavioGalimberti2012VoltageGated). The S4 segment acts as the voltage sensor, while the S5-S6 segments form the pore of the channel, including a selectivity filter that controls ion selectivity and permeation (SavioGalimberti2012VoltageGated).

The secondary structure includes alpha helices and beta sheets, which contribute to the channel's functional conformation. The tertiary structure involves the folding of these helices and sheets into a three-dimensional shape, crucial for channel function. The quaternary structure may involve interactions with β-subunits, which modulate the expression and function of the channel (SavioGalimberti2012VoltageGated).

SCN10A is subject to post-translational modifications such as phosphorylation, which can regulate its activity. The gene also produces splice variant isoforms, which may have different functional properties (de2015Voltage-Gated). These structural features are essential for the channel's role in transmitting action potentials and its involvement in pain signaling and cardiac conduction (SavioGalimberti2012VoltageGated; de2015Voltage-Gated).

## Function
The SCN10A gene encodes the voltage-gated sodium channel NaV1.8, which plays a significant role in various physiological processes. In human sperm cells, NaV1.8 is involved in regulating sperm motility, a critical function for fertilization. It is expressed in the neck and principal piece of the sperm flagellum, where it modulates ion transport across the plasma membrane, influencing sperm motility and flagellar activity (CejudoRoman2013The).

In cardiac physiology, SCN10A is associated with cardiac conduction and arrhythmias. Although its expression in adult cardiac tissue is low, SCN10A variants modulate the expression of the SCN5A gene, which is crucial for cardiac conduction. This modulation occurs through enhancer interactions that influence SCN5A expression, impacting cardiac rhythm and conduction (van2014A). NaV1.8 contributes to the late sodium current (INaL) in cardiac cells, which is implicated in arrhythmogenesis, particularly in atrial cardiomyocytes (Hartmann2023Molecular).

Overall, SCN10A plays a role in both reproductive and cardiac functions, with its activity influencing sperm motility and cardiac conduction through its effects on ion transport and gene expression regulation.

## Clinical Significance
Mutations and genetic variations in the SCN10A gene have been associated with several cardiac conditions. Deleterious mutations in SCN10A are linked to prolonged QT intervals, which can lead to cardiac arrhythmias such as atrial fibrillation and syncope. These mutations are often found in individuals with a family history of arrhythmias, suggesting an autosomal dominant inheritance pattern (Abou2017Deleterious). 

In patients with hypertrophic cardiomyopathy, SCN10A polymorphisms, particularly rs6795970, have been associated with cardiac conduction abnormalities, including first-degree heart block and bundle-branch block. This polymorphism results in a gain-of-function variant that alters cardiac conduction (Iio2015Association). 

SCN10A variants also play a role in Brugada Syndrome (BrS). The V1073 variant is associated with a loss-of-function phenotype and is linked to BrS, while the A1073 variant is considered protective (Behr2015Role). 

Additionally, the SCN10A gene influences cardiac conduction by modulating SCN5A expression. Variants like rs6801957 in the SCN10A enhancer region can disrupt normal SCN5A expression, leading to conduction slowing and arrhythmias (van2014A).

## Interactions
The SCN10A gene encodes the NaV1.8 sodium channel, which is involved in various protein interactions that influence its function and regulation. NaV1.8 interacts with Ca2+/calmodulin-dependent protein kinase IIδc (CaMKIIδc), a relationship that is particularly significant in the context of heart failure. This interaction contributes to the formation of the late sodium current (I_NaL), which is associated with proarrhythmic activity in failing hearts. Inhibition of NaV1.8 has been shown to reduce diastolic sarcoplasmic reticulum Ca2+ leak and arrhythmic events, suggesting its potential as a therapeutic target in heart failure (Bengel2021Detrimental).

NaV1.8 also interacts with calmodulin (CaM), which modulates the channel's activity. CaM binds to the IQ domain of NaV1.8, enhancing slow inactivation and reducing channel availability. This interaction is crucial for the frequency-dependent inhibition of sodium channels in dorsal root ganglia neurons, and mutations that disrupt CaM binding can affect channel regulation (Wu2021Calmodulin).

These interactions highlight the role of NaV1.8 in cardiac electrophysiology and its regulation by CaMKIIδc and CaM, which are important for understanding its function in both normal and pathological conditions.


## References


[1. (Iio2015Association) Chiharuko Iio, Akiyoshi Ogimoto, Takayuki Nagai, Jun Suzuki, Katsuji Inoue, Kazuhisa Nishimura, Teruyoshi Uetani, Hideki Okayama, Takafumi Okura, Yuji Shigematsu, Yasuharu Tabara, Katsuhiko Kohara, Tetsuro Miki, Mareomi Hamada, and Jitsuo Higaki. Association between genetic variation in the &lt;i&gt;scn10a&lt;/i&gt; gene and cardiac conduction abnormalities in patients with hypertrophic cardiomyopathy. International Heart Journal, 56(4):421–427, 2015. URL: http://dx.doi.org/10.1536/ihj.14-411, doi:10.1536/ihj.14-411. This article has 16 citations and is from a peer-reviewed journal.](https://doi.org/10.1536/ihj.14-411)

[2. (Hartmann2023Molecular) Nico Hartmann, Maria Knierim, Wiebke Maurer, Nataliya Dybkova, Gerd Hasenfuß, Samuel Sossalla, and Katrin Streckfuss-Bömeke. Molecular and functional relevance of nav1.8-induced atrial arrhythmogenic triggers in a human scn10a knock-out stem cell model. International Journal of Molecular Sciences, 24(12):10189, June 2023. URL: http://dx.doi.org/10.3390/ijms241210189, doi:10.3390/ijms241210189. This article has 4 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms241210189)

[3. (van2014A) Malou van den Boogaard, Scott Smemo, Ozanna Burnicka-Turek, David E. Arnolds, Harmen J.G. van de Werken, Petra Klous, David McKean, Jochen D. Muehlschlegel, Julia Moosmann, Okan Toka, Xinan H. Yang, Tamara T. Koopmann, Michiel E. Adriaens, Connie R. Bezzina, Wouter de Laat, Christine Seidman, J.G. Seidman, Vincent M. Christoffels, Marcelo A. Nobrega, Phil Barnett, and Ivan P. Moskowitz. A common genetic variant within scn10a modulates cardiac scn5a expression. Journal of Clinical Investigation, 124(4):1844–1852, March 2014. URL: http://dx.doi.org/10.1172/jci73140, doi:10.1172/jci73140. This article has 166 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1172/jci73140)

[4. (SavioGalimberti2012VoltageGated) Eleonora Savio-Galimberti, Michael H. Gollob, and Dawood Darbar. Voltage-gated sodium channels: biophysics, pharmacology, and related channelopathies. Frontiers in Pharmacology, 2012. URL: http://dx.doi.org/10.3389/fphar.2012.00124, doi:10.3389/fphar.2012.00124. This article has 83 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fphar.2012.00124)

[5. (de2015Voltage-Gated) Manuel de Lera Ruiz and Richard L. Kraus. Voltage-gated sodium channels: structure, function, pharmacology, and clinical indications. Journal of Medicinal Chemistry, 58(18):7093–7118, May 2015. URL: http://dx.doi.org/10.1021/jm501981g, doi:10.1021/jm501981g. This article has 377 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1021/jm501981g)

[6. (Behr2015Role) Elijah R. Behr, Eleonora Savio-Galimberti, Julien Barc, Anders G. Holst, Evmorfia Petropoulou, Bram P. Prins, Javad Jabbari, Margherita Torchio, Myriam Berthet, Yuka Mizusawa, Tao Yang, Eline A. Nannenberg, Federica Dagradi, Peter Weeke, Rachel Bastiaenan, Michael J. Ackerman, Stig Haunso, Antoine Leenhardt, Stefan Kääb, Vincent Probst, Richard Redon, Sanjay Sharma, Arthur Wilde, Jacob Tfelt-Hansen, Peter Schwartz, Dan M. Roden, Connie R. Bezzina, Morten Olesen, Dawood Darbar, Pascale Guicheney, Lia Crotti, and Yalda Jamshidi. Role of common and rare variants in scn10a: results from the brugada syndrome qrs locus gene discovery collaborative study. Cardiovascular Research, 106(3):520–529, February 2015. URL: http://dx.doi.org/10.1093/cvr/cvv042, doi:10.1093/cvr/cvv042. This article has 96 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1093/cvr/cvv042)

[7. (Wu2021Calmodulin) Xin Wu and Liang Hong. Calmodulin interactions with voltage-gated sodium channels. International Journal of Molecular Sciences, 22(18):9798, September 2021. URL: http://dx.doi.org/10.3390/ijms22189798, doi:10.3390/ijms22189798. This article has 13 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms22189798)

[8. (Bengel2021Detrimental) Philipp Bengel, Nataliya Dybkova, Petros Tirilomis, Shakil Ahmad, Nico Hartmann, Belal A. Mohamed, Miriam Celine Krekeler, Wiebke Maurer, Steffen Pabel, Maximilian Trum, Julian Mustroph, Jan Gummert, Hendrik Milting, Stefan Wagner, Senka Ljubojevic-Holzer, Karl Toischer, Lars S. Maier, Gerd Hasenfuss, Katrin Streckfuss-Bömeke, and Samuel Sossalla. Detrimental proarrhythmogenic interaction of ca2+/calmodulin-dependent protein kinase ii and nav1.8 in heart failure. Nature Communications, November 2021. URL: http://dx.doi.org/10.1038/s41467-021-26690-1, doi:10.1038/s41467-021-26690-1. This article has 16 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/s41467-021-26690-1)

[9. (CejudoRoman2013The) Antonio Cejudo-Roman, Francisco M. Pinto, Nerea Subirán, Cristina G. Ravina, Manuel Fernández-Sánchez, Natalia Pérez-Hernández, Ricardo Pérez, Alberto Pacheco, Jon Irazusta, and Luz Candenas. The voltage-gated sodium channel nav1.8 is expressed in human sperm. PLoS ONE, 8(9):e76084, September 2013. URL: http://dx.doi.org/10.1371/journal.pone.0076084, doi:10.1371/journal.pone.0076084. This article has 27 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0076084)

[10. (Abou2017Deleterious) M.D. Abou Ziki, S.B. Seidelmann, E. Smith, G. Atteya, Y. Jiang, R.G. Fernandes, M.A. Marieb, J.G. Akar, and A. Mani. Deleterious protein‐altering mutations in the <scp>scn10a</scp> voltage‐gated sodium channel gene are associated with prolonged <scp>qt</scp>. Clinical Genetics, 93(4):741–751, May 2017. URL: http://dx.doi.org/10.1111/cge.13036, doi:10.1111/cge.13036. This article has 10 citations and is from a peer-reviewed journal.](https://doi.org/10.1111/cge.13036)